En español

Menu

Publications

Quick Links

Funding Application - Request for Applications

RFAs Issued by NIDA

Title RFA ID Letter of Intent Receipt Date Application Due Date
Exploiting Omics Assays to Investigate Molecular Regulation of Persistent HIV in Individuals with Substance Use Disorder (Clinical Trial Optional) RFA-DA-19-003 (R61/R33) June 17, 2020 July 17, 2020
HEAL Initiative: Americas Startups and Small Businesses Build Technologies to Stop the Opioid Epidemic (Clinical Trial Optional) RFA-DA-19-019 (R43/R44)
RFA-DA-19-020 (R41/R42)
March 08, 2020 April 09, 2020
Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Coordination, Analysis, and Scientific Outreach (Clinical Trial Not Allowed) RFA-DA-20-027 (UM1) December 15, 2019 January 15, 2020
Targeting Inflammasomes in Substance Abuse and HIV (Clinical Trial Not Allowed) RFA-DA-20-026 (R01) December 15, 2019 January 15, 2020
Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose UG3/UH3) (Clinical Trials Optional) RFA-DA-19-002 Rolling Acceptance (See RFA) Rolling Acceptance (See RFA)

Other RFAs in which NIDA Participates

Title RFA ID Letter of Intent Receipt Date Application Due Date
Discovery of Biomarkers, Biomarker Signatures, and Endpoints for Pain (Clinical Trial Optional) RFA-NS-18-041 (R61/R33) February 10, 2020 March 12, 2020
HEAL Initiative: Clinical Devices to Treat Pain (Clinical Trial Optional) RFA-NS-19-018 (UH3) December 09, 2018 February 21, 2020
HEAL Initiative: Translational Development of Devices to Treat Pain (Clinical Trial Not Allowed) RFA-EB-18-003 (U18) February 20, 2019 February 21, 2020
HEAL Initiative: Translational Devices to Treat Pain (Clinical Trial Optional) RFA-NS-19-016 (UG3/UH3) December 09, 2018 February 21, 2020